Navigation Links
New Treatment Aids Weight Loss, Improves Diabetes in Monkeys
Date:11/28/2012

By Serena Gordon
HealthDay Reporter

WEDNESDAY, Nov. 28 (HealthDay News) -- A new, lab-created antibody that mimics the action of a naturally occurring molecule causes weight loss in monkeys, researchers report.

The engineered antibody also appears to improve insulin sensitivity, which could fight type 2 diabetes, and it decreases levels of triglycerides, a blood fat that contributes to hardening of the arteries.

"The results we describe in animal models are profound and very encouraging," said study senior author Yang Li, scientific director at Amgen, Inc., in Thousand Oaks, Calif. "While we're excited about these findings, we're still evaluating the results."

Li said it's important to remember these findings were in monkeys and only in a preclinical setting. It's not yet clear how this treatment might act in humans.

The study was funded by Amgen, the developer of the new treatment. The findings are published in the Nov. 28 issue of Science Translational Medicine.

Obesity and its frequent companion, type 2 diabetes, are growing problems in the United States that threaten to overwhelm the health care system if they continue to increase, according to the U.S. Centers for Disease Control and Prevention. Obesity treatments generally aren't effective in the long term, and while medications are available for type 2 diabetes, many people with the disease aren't able to achieve blood sugar levels low enough to avoid complications, according to the American Diabetes Association.

The current study began by looking at a molecule called fibroblast growth factor 21 (FGF21). This molecule has garnered a lot of research interest lately because it appears to have many positive effects on obesity and type 2 diabetes, according to the study.

In the body, FGF21 is induced during fasting or starvation. Scientists are still trying to understand how FGF21 causes beneficial changes, but suspect it may activate the less common but more metabolically active brown fat.

Developing FGF21 into a treatment is challenging, Li said, because the molecule isn't stable in the blood. That means any treatment developed from the natural protein might require frequent injections, he said.

In the current research, Li and his colleagues took a different approach. Instead of looking at FGF21, the researchers attempted to find other, more stable ways to activate the same pathways activated by FGF21.

The researchers engineered an alternative in the lab -- an antibody called mimAb1. They tested the new antibody on 10 obese monkeys and compared them to another 10 obese monkeys in a control group.

The monkeys in the treatment group received two injections -- one the first week and another the third week. Five to six weeks after the first injection the monkeys had lost 10 percent of their body weight. The reductions in body weight were maintained at least nine weeks after the second injection.

What's more, the weight loss appeared to occur even without a significant reduction in calories, Li said.

In addition to weight loss and improved insulin sensitivity, the animals' abdominal circumference and body-mass index (BMI) decreased. BMI is a measure of body fat based on height and weight.

"When we tested mimAb1 in the animal model, we saw a lot of beneficial changes. The results were quite encouraging," Li said. He added that they didn't see any significant side effects, including low blood sugar levels.

Dr. Spyros Mezitis, an endocrinologist at Lenox Hill Hospital in New York City, said the study was well done, but it's very preliminary.

"There is promise here. This pathway has beneficial effects when turned on, and needs to be looked into further," Mezitis said. "We have to make sure it works the same way in humans, and that it's safe. This might take years to pan out."

He said it's also possible that although this particular treatment may not be the answer for human obesity or diabetes, it may provide more clues into the mechanisms behind these conditions.

More information

Read more about current ways to maintain a healthy weight from the U.S. National Heart, Lung, and Blood Institute.

SOURCES: Yang Li, Ph.D., scientific director, Amgen, Inc., Thousand Oaks, Calif.; Spyros Mezitis, M.D., endocrinologist, Lenox Hill Hospital, New York City; Nov. 28, 2012, Science Translational Medicine


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New hope for setback-dogged cancer treatment
2. The hidden disorder: Unique treatment proposed for childrens neurological disorder
3. Drug resistance biomarker could improve cancer treatment
4. Pathway identified in human lymphoma points way to new blood cancer treatments
5. Scientists win funding to study new treatment for severe chronic pain
6. Researchers find decline in availability and use of key treatment for depression
7. New technology for a more efficient treatment of Pompe disease and other metabolic disorders
8. Hepatitis C treatments side effects can now be studied in the lab
9. Researchers report potential new treatment to stop Alzheimers disease
10. Study shows bone metastases treatment can improve overall survival
11. GW researcher receives $4.1 million grant to find alternative treatment for kidney stones
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Treatment Aids Weight Loss, Improves Diabetes in Monkeys
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun ... NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is ... is geared towards children of all ages; it is a non-competitive, non-timed event, which ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United ... year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and ... havens have extremely low property-tax rates, which contributes to the relatively lower cost ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
(Date:9/22/2017)... AVACEN Medical (AVACEN) announced that its CE-Marked ... those with the widespread pain associated with fibromyalgia in ... Essex, England commented, "I had ... no sleep at all, tremendous pain, with every movement ... [the AVACEN 100] enough, how this has and is ...
Breaking Medicine Technology: